Northern Trust’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.97M | Buy |
611,161
+75,164
| +14% | +$489K | ﹤0.01% | 2593 |
|
|
2025
Q1 | $4.25M | Sell |
535,997
-11,053
| -2% | -$87.7K | ﹤0.01% | 2507 |
|
|
2024
Q4 | $6.93M | Buy |
547,050
+51,960
| +10% | +$658K | ﹤0.01% | 2330 |
|
|
2024
Q3 | $6.9M | Sell |
495,090
-37,949
| -7% | -$529K | ﹤0.01% | 2290 |
|
|
2024
Q2 | $7.35M | Sell |
533,039
-25,106
| -4% | -$346K | ﹤0.01% | 2177 |
|
|
2024
Q1 | $9.22M | Sell |
558,145
-18,607
| -3% | -$307K | ﹤0.01% | 2086 |
|
|
2023
Q4 | $8.42M | Buy |
576,752
+24,898
| +5% | +$364K | ﹤0.01% | 2177 |
|
|
2023
Q3 | $6.77M | Buy |
551,854
+119,262
| +28% | +$1.46M | ﹤0.01% | 2256 |
|
|
2023
Q2 | $5.17M | Buy |
432,592
+213,071
| +97% | +$2.54M | ﹤0.01% | 2479 |
|
|
2023
Q1 | $2.93M | Sell |
219,521
-5,748
| -3% | -$76.9K | ﹤0.01% | 2763 |
|
|
2022
Q4 | $4.85M | Buy |
225,269
+219
| +0.1% | +$4.71K | ﹤0.01% | 2509 |
|
|
2022
Q3 | $4.51M | Buy |
225,050
+34,540
| +18% | +$692K | ﹤0.01% | 2554 |
|
|
2022
Q2 | $3.41M | Buy |
190,510
+20,211
| +12% | +$362K | ﹤0.01% | 2756 |
|
|
2022
Q1 | $1.69M | Buy |
170,299
+66,622
| +64% | +$661K | ﹤0.01% | 3179 |
|
|
2021
Q4 | $1.75M | Buy |
103,677
+5,578
| +6% | +$94K | ﹤0.01% | 3288 |
|
|
2021
Q3 | $2.33M | Buy |
98,099
+85,381
| +671% | +$2.03M | ﹤0.01% | 3208 |
|
|
2021
Q2 | $290K | Buy |
+12,718
| New | +$290K | ﹤0.01% | 3956 |
|